Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,755 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population.
Sumida Y, Yoneda M, Hyogo H, Itoh Y, Ono M, Fujii H, Eguchi Y, Suzuki Y, Aoki N, Kanemasa K, Fujita K, Chayama K, Saibara T, Kawada N, Fujimoto K, Kohgo Y, Yoshikawa T, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD). Sumida Y, et al. Among authors: yoshikawa t. BMC Gastroenterol. 2012 Jan 5;12:2. doi: 10.1186/1471-230X-12-2. BMC Gastroenterol. 2012. PMID: 22221544 Free PMC article.
Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease.
Park H, Shima T, Yamaguchi K, Mitsuyoshi H, Minami M, Yasui K, Itoh Y, Yoshikawa T, Fukui M, Hasegawa G, Nakamura N, Ohta M, Obayashi H, Okanoue T. Park H, et al. Among authors: yoshikawa t. J Gastroenterol. 2011 Jan;46(1):101-7. doi: 10.1007/s00535-010-0291-8. Epub 2010 Jul 24. J Gastroenterol. 2011. PMID: 20658156 Clinical Trial.
Platelet count for predicting fibrosis in nonalcoholic fatty liver disease.
Yoneda M, Fujii H, Sumida Y, Hyogo H, Itoh Y, Ono M, Eguchi Y, Suzuki Y, Aoki N, Kanemasa K, Imajo K, Chayama K, Saibara T, Kawada N, Fujimoto K, Kohgo Y, Yoshikawa T, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver Disease. Yoneda M, et al. Among authors: yoshikawa t. J Gastroenterol. 2011 Nov;46(11):1300-6. doi: 10.1007/s00535-011-0436-4. Epub 2011 Jul 13. J Gastroenterol. 2011. PMID: 21750883
Noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase levels.
Yoneda M, Imajo K, Eguchi Y, Fujii H, Sumida Y, Hyogo H, Ono M, Suzuki Y, Kawaguchi T, Aoki N, Sata M, Kanemasa K, Kohgo Y, Saibara T, Chayama K, Itoh Y, Yoshikawa T, Anzai K, Fujimoto K, Okanoue T, Nakajima A; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD). Yoneda M, et al. Among authors: yoshikawa t. J Gastroenterol. 2013 Sep;48(9):1051-60. doi: 10.1007/s00535-012-0704-y. Epub 2012 Nov 27. J Gastroenterol. 2013. PMID: 23184095
The association of insomnia with gastroesophageal reflux symptoms in biopsy-proven nonalcoholic fatty liver disease.
Taketani H, Sumida Y, Tanaka S, Imajo K, Yoneda M, Hyogo H, Ono M, Fujii H, Eguchi Y, Kanemasa K, Chayama K, Itoh Y, Yoshikawa T, Saibara T, Fujimoto K, Nakajima A; Japan Study Group of NAFLD. Taketani H, et al. Among authors: yoshikawa t. J Gastroenterol. 2014 Jul;49(7):1163-74. doi: 10.1007/s00535-013-0871-5. Epub 2013 Aug 22. J Gastroenterol. 2014. PMID: 23975270
The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation.
Hamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, Nakajima T, Kato T, Takeda N, Okuda J, Ida K, Kawahito Y, Yoshikawa T, Okanoue T. Hamaguchi M, et al. Among authors: yoshikawa t. Am J Gastroenterol. 2007 Dec;102(12):2708-15. doi: 10.1111/j.1572-0241.2007.01526.x. Epub 2007 Sep 25. Am J Gastroenterol. 2007. PMID: 17894848
Role of hepatic iron in non-alcoholic steatohepatitis.
Sumida Y, Yoshikawa T, Okanoue T. Sumida Y, et al. Among authors: yoshikawa t. Hepatol Res. 2009 Mar;39(3):213-22. doi: 10.1111/j.1872-034X.2008.00442.x. Hepatol Res. 2009. PMID: 19261002
Hepatic senescence marker protein-30 is involved in the progression of nonalcoholic fatty liver disease.
Park H, Ishigami A, Shima T, Mizuno M, Maruyama N, Yamaguchi K, Mitsuyoshi H, Minami M, Yasui K, Itoh Y, Yoshikawa T, Fukui M, Hasegawa G, Nakamura N, Ohta M, Obayashi H, Okanoue T. Park H, et al. Among authors: yoshikawa t. J Gastroenterol. 2010 Apr;45(4):426-34. doi: 10.1007/s00535-009-0154-3. Epub 2009 Nov 28. J Gastroenterol. 2010. PMID: 19946731
Nonalcoholic steatohepatitis and increased risk of chronic kidney disease.
Yasui K, Sumida Y, Mori Y, Mitsuyoshi H, Minami M, Itoh Y, Kanemasa K, Matsubara H, Okanoue T, Yoshikawa T. Yasui K, et al. Among authors: yoshikawa t. Metabolism. 2011 May;60(5):735-9. doi: 10.1016/j.metabol.2010.07.022. Epub 2010 Sep 3. Metabolism. 2011. PMID: 20817213
4,755 results